Respiratory News and Research

RSS

Scotland's doctors unite in calls for smoke free public places

As part of the BMA's 'Breathe better in Scotland' campaign, senior doctors today (Wednesday 29 September) delivered 1000 letters from doctors in Scotland calling on the First Minister, Jack McConnell, to legislate for smokefree public places.

29 Sep 2004

Chiron CEO to appear before the U.S. Senate Special Committee on Aging

Chiron Corporation announced that president and chief executive officer Howard Pien will appear before the U.S. Senate Special Committee on Aging in Washington, D.C., today in a hearing titled, "Combating the Flu: Keeping Seniors Alive."

28 Sep 2004

PAHO outlines health challenges ahead

Pan American Health Organization (PAHO) Director Dr. Mirta Roses today presented a report summarizing PAHO's work over the past year in the Americas, during a special session of a meeting of the region's ministers of health taking place at PAHO headquarters this week.

28 Sep 2004

Master gene that controls the first breath a newborn infant

Researchers at Cincinnati Children's Hospital Medical Center have identified a master gene that controls the first breath a newborn infant takes. The findings could have implications for treating premature babies and children and adults with lung disease or lung injury.

28 Sep 2004

Outbreak of whooping cough in South Australia

South Australia's Department of Health is urging parents to make sure their children are immunised against whooping cough as an outbreak is beginning in SA.

28 Sep 2004

Ranbaxy receives FDA approval to market Loratadine and Pseudoephedrine Sulfate extended release tablets

Ranbaxy Pharmaceuticals, a wholly-owned subsidiary of Ranbaxy Laboratories Limited of New Delhi, India, announced today that RLL has received approval from the U. S. Food and Drug Administration to manufacture and market Loratadine and Pseudoephedrine Sulfate Extended Release Tablets

26 Sep 2004

Palladone approved for pain relief

The Food and Drug Administration (FDA) has approved Palladone (hydromorphone hydrochloride) capsules for the management of persistent moderate to severe pain in patients requiring continuous around-the-clock opioid pain relief for an extended period of time.

26 Sep 2004

Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder

AstraZeneca has announced important new data at the 4th European Stanley Foundation Conference on Bipolar Disorder, which show Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder and is also well-tolerated in this difficult to treat patient population.

26 Sep 2004

Allow genomic information to be freely available on the internet

This week’s lead editorial in THE LANCET discusses the benefits and potential risks of allowing genomic information to be freely available on the internet

23 Sep 2004

Pneumonia could be treatable by the oral antibiotic amoxicillin rather than injectable penicillin

Pneumonia - one of the world’s deadliest diseases for young children in developing countries - could be treatable by the oral antibiotic amoxicillin rather than injectable penicillin, with implications for better health outcomes and reduced costs

23 Sep 2004

PA Consulting sells drug delivery venture, Meridica, to Pfizer

Pfizer and PA Consulting Group have announced the signing of a transaction in which Pfizer will purchase the remaining 90% ownership of Meridica Limited

23 Sep 2004

Study on the long-term health effects associated with silicone breast implants

It is estimated that between 1.5 million and 2 million women in this country have had breast implants since they first appeared on the market in 1962.

23 Sep 2004

Potential new way to control drug-resistant bacteria

The researchers, who encountered this genetic property while working on an unrelated project, believe that this discovery could lead to the use of genetically engineered phages to treat bacterial infections that have become resistant to antibiotics.

23 Sep 2004

Whooping cough at highest levels since 1997 in Western Australia

Western Australia is experiencing the highest level of whooping cough (pertussis) notifications since 1997, when more than 1200 cases were notified.

22 Sep 2004

BMA Cymru Wales to launch no smoking campaign

BMA Cymru Wales will tomorrow be launching its 'Let the Dragon Breathe' poster campaign at the National Assembly for Wales after a meeting of the Assembly's committee on smoking in public places.

22 Sep 2004

Imperative that strategies to control tuberculosis include measures to treat individuals with MDR disease

Challenging the notion that multidrug-resistant tuberculosis (MDR-TB) poses a low threat to populations, epidemiologists at the Harvard School of Public Health (HSPH) have constructed a mathematical model of the disease variant's potential course

20 Sep 2004

Global health is recurrently being threatened by new and re-emerging infectious diseases

Global health is recurrently being threatened by new and re-emerging infectious diseases. Examples of new and re-emerging infectious diseases include SARS (Severe Acute Respiratory Syndrome), new variant CJD (Creutzfeldt-Jakob Disease), avian flu and Ebola.

20 Sep 2004